Osteomyelitis: Keys To Diagnosis And Treatment

Start Page: 42
Gina A. Hild, DPM, and Allan M. Boike, DPM, FACFAS

27. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot’s neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007; 28(6):465-472.
28. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004; 25(12):890-895.
29. Rushton N. Applications of local antibiotic therapy. Eur J Surg Suppl. 1997; (578):27-30.
30. Wilson KJ, Cierny G, Adams KR, Mader JT. Comparative evaluation of the diffusion of tobramycin and cefotaxime out of antibiotic-impregnated polymethylmethacrylate beads. J Orthop Res. 1988; 6(2):279-286.
31. Beuerlein MJ, McKee MD. Calcium sulfates: what is the evidence? J Orthop Trauma. 2010; 24(Suppl 1):S46-51.
32. Kent ME, Rapp RP, Smith KM. Antibiotic beads and osteomyelitis: here today, what’s coming tomorrow? Orthopedics. 2006; 29(7):599-603.
33. Jacobs AM, Cheng D. Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5’-phosphate. Rev Neurol Dis. 2011; 8(1-2):39-47.

   For further reading, see “Emerging Insights In Diagnosing And Treating Osteomyelitis” in the July 2012 issue of Podiatry Today.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Enter the characters shown in the image.